The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 82.00% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 73.24%. Over the past 30 days, the price of LUCD has fallen by 75.31%. And in the last five days, it has surged by 12.03%.
In terms of market performance, Lucid Diagnostics Inc had a fairly even. The highest value for the stock in the past year was $1.63 on 02/19/25, and the lowest value was recorded at $0.63 on 04/25/24.
52-week price history of LUCD Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Lucid Diagnostics Inc’s current trading price is -8.76% away from its 52-week high, while its distance from the 52-week low is 136.47%. The stock’s price range during this time has been between $0.63 and $1.63. The trading volume for the Healthcare sector company’s shares reached about 0.66 million for the day, which was higher than the average daily volume of 0.52 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Lucid Diagnostics Inc (LUCD) has experienced a quarterly rise of 50.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 88.42M and boasts a workforce of 70 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9226, with a change in price of +0.7302. Similarly, Lucid Diagnostics Inc recorded 452,690 in trading volume during the last 100 days, posting a change of +96.10%.
LUCD’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LUCD stands at 2.06. Similarly, the long-term debt-to-equity ratio is also 0.32.
LUCD Stock Stochastic Average
Today’s raw stochastic average for Lucid Diagnostics Inc over the last 50 days is 83.80%.This indicates a increase from the raw stochastic average of the past 20 days, which was 82.41%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 91.97% and 94.08%, respectively.
